Dr. Margalit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-3591- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2007 - 2011
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2006 - 2010
- Brigham and Women's HospitalResidency, Internal Medicine, 2006 - 2007
- Harvard Medical SchoolClass of 2006
Certifications & Licensure
- ME State Medical License 2020 - 2025
- MA State Medical License 2008 - 2024
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer Start of enrollment: 2013 Feb 01
- Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma Start of enrollment: 2019 May 20
Publications & Presentations
PubMed
- Carotid Artery Stenosis and Ischemic Stroke in Patients with Head and Neck Cancer Treated with Radiotherapy: A Critical Review.Justin Smith, Jonathan Golledge, Domenico Nastasi, Lachlan McDowell, Danielle Margalit, Anju Nohria> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Apr 5
- Outcomes of palliative radiation therapy for cutaneous squamous cell carcinoma: A retrospective cohort study.Kim, E., Granger, E., Silk, A., Schoenfeld, J., Margalit, D., Tishler, R., Ruiz, E.> ;JAAD International. 2024 Mar 1
- Neoadjuvant chemotherapy for advanced oral cavity cancer.Yaniv, D., Barbon, C., Smith, J., Gross, N., Seiwert, T., Margalit, D., Williams, M., Largo, R.> ;CA. 2024 Feb 8
- Join now to see all
Press Mentions
- High Rates of Oropharynx Cancer Tied to HPVSeptember 11th, 2019
- Estimate of the National Burden of HPV-Positive Oropharyngeal Head and Neck CancersAugust 29th, 2019
- Adding Nivolumab to Standard First-Line Therapy Feasible in Advanced Head and Neck CancerFebruary 20th, 2018
Hospital Affiliations
- Dana-Farber Cancer InstituteBoston, Massachusetts
- Brigham and Women's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: